NEW YORK STOCK EXCHANGE, INC. · ELAN
+0.50% · +$0.1200 · Vol 4.5M
Elanco Animal Health Inc

Elanco Animal Health Inc

Pharmaceuticals
$24.17

Veridion Score

Loading
Score loading…
Veridion Score History · 90D

Composite trend over time

LOADING HISTORY…
REFRESHES DAILY
AI Analysis
Sovereign

Why is ELAN moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Elanco Animal Health Inc
PHARMACEUTICAL PREPARATIONS
Founded
Listed
2018
Employees
10K
HQ
US

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.

Key statistics

Real vendor fields plus Veridion-computed history. Missing fields stay blank.

Open
$24.27
Day high
$24.41
Day low
$24.00
Previous close
$24.05
52W high
$24.17
0.00% from high
52W low
$23.06
100% of range
Market cap
$12.1B
P/E
EPS
Dividend yield
Beta
Shares out
499.4M
Float
Volume
4.5M
Avg volume
VWAP
$24.20
Next earnings
Price history computed in-house
1W
+4.63%
1M
+4.63%
3M
+4.63%
1Y
+4.63%
YTD
+4.63%
SMA 50 $23.61 · above
SMA 200 $23.61 · above
52W position 100%
Veridion warehouse edge

Warehouse intelligence for ELAN.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Loading quarterly statements…
SEC Form 4 ledger

ELAN insider activity

Elanco Animal Health Inc

Score
Coverage building
Pressure
Net selling
Filings
97
Buys / sells
74 / 23
Net value
-$11.2M
Insiders
13
Named filers
MA
Modi Rajeev A.
Insider
Leadership
VM
VanHimbergen Robert M
Insider
Leadership
SN
Simmons Jeffrey N
Insider
Leadership
Cluster

4 insiders bought in the last 90 days

Net pressure

Net selling: -$11.2M across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Filing dateTrade dateInsiderTitleTypePriceQtyOwnedValueReceipt
2026-06-022026-05-29Modi Rajeev A.Insiderbuy$23.85629,402$1KSEC Form 4
2026-06-022026-05-29VanHimbergen Robert MInsiderbuy$23.85893$191SEC Form 4
2026-06-022026-05-29Simmons Jeffrey NInsiderbuy$23.8511924,425$3KSEC Form 4
2026-05-192026-05-15Modi Rajeev A.Insiderbuy$19.86749,340$1KSEC Form 4
2026-05-192026-05-15Modi Rajeev A.Insiderbuy$20.354,911160,812$100KSEC Form 4
Full Form 4 history requires Sovereign

Showing 5 recent rows. Sovereign unlocks 92 additional rows, full sorting, and the named-filer history.

Upgrade to Sovereign · $25/mo
Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Loading PTR filings…
Federal contracts

ELAN contract awards, year to date.

Public federal awards linked to this ticker.

Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ELAN in this window.
Lobbying spend

ELAN lobbying filings, year to date.

Registered lobbying filings matched to Elanco Animal Health Inc.

Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ELAN in this window.
Latest news · ELAN
Refresh interval: 5 minutes · Source: Market news insights
Loading articles…
Analyst ratings
Sovereign unlock shows live analyst consensus for ELAN.
Options
Sovereign unlock shows live options positioning for ELAN.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.